Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.
Active pharmaceutical ingredients (APIs) form the backbone of modern medicine, driving the efficacy and safety of countless therapeutic products. According to a recent report by MarketsandMarkets, the ...
After tariffs rose to the highest levels in centuries, the U.S. lost tens of thousands of manufacturing jobs last year. In December, WSJ’s Gavin Bade went inside Detroit to learn why—and meet the ...
BETHLEHEM, Pa.--(BUSINESS WIRE)--Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active pharmaceutical ingredients (APIs) and critical ...
Agno Pharma Acquires Actylis’s CDMO Manufacturing Asset, the Legacy Cascade Chemistry Business based in Eugene, Oregon, Strengthening Agno’s US cGMP API Development and Manufacturing Capabilities Agno ...
Oil industry executives have voiced that reviving Venezuela's oil production will be a long and costly process. Companies will need stable, legally defined frameworks, security for investments, and ...
Saharsh Davuluri, Neuland Labs, urges API and peptide automation by 2026 to match modern biologics standards. PharmTech recently spoke with Saharsh Davuluri, Vice Chairman and Managing Director, ...
Inke is a manufacturer of inhalation active pharmaceutical ingredients Inke is based in Barcelona, Spain Pharmanoid’s products are authorized for commercialization in more than 25 countries Inke, ...
EAST RUTHERFORD, N.J., Oct. 22, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced a $120 million investment to expand its U.S.
Throughout 2025, drugmakers of all stripes have collectively poured billions of dollars into U.S. manufacturing investments. Many of those projects have centered on later stages of the production ...
After months of merchant frustration over securing the required API key for website-reported local inventory feeds via Google Tag Manager, Google has now confirmed a straightforward process: Why we ...